Matthew Buten Biohaven Pharmaceutical Holding CO Ltd. (BHVN) insider trading activity

BHVN Quotes by TradingView

Matthew Buten is Chief Financial Officer of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 0 shares of BHVN, which is worth approximately $0. The most recent transaction as insider was on Oct 03, 2022, when has been sold 6,177 shares (Common Shares) at a price of $148.5 per share, resulting in proceeds of $917,284. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Matthew Buten Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2022
SELL
Sale (or disposition) back to the issuer
$917,284 $148.5 p/Share
6,177 Reduced 100.0%
0 Common Shares
Dec 31 2021
SELL
Payment of exercise price or tax liability
$871,373 $137.81 p/Share
6,323 Reduced 50.58%
6,177 Common Shares
Dec 31 2021
BUY
Exercise of conversion of derivative security
-
12,500 Added 50.0%
12,500 Common Shares

Also insider at

BHVN
Biohaven Ltd.
Chief Financial Officer
MB

Matthew Buten

Chief Financial Officer
New Haven, CT

Track Institutional and Insider Activities on BHVN

Follow Biohaven Pharmaceutical Holding Co Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHVN shares.

Notify only if

Insider Trading

Get notified when an Biohaven Pharmaceutical Holding CO Ltd. insider buys or sells BHVN shares.

Notify only if

News

Receive news related to Biohaven Pharmaceutical Holding Co Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BHVN